Relation between disease phenotype and HLA-DQ genotype in diabetic patients diagnosed in early adulthood

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 6, 2002, Pages 2597-2605

  Weets, Ilse ^a   Siraux, Valerie ^b   Daubresse, Jean Claude ^c   De Leeuw, Ivo H ^d   Féry, Francoise ^e   Keymeulen, Bart ^f   Krzentowski, Georges ^g   Letiexhe, Michel ^h   Mathieu, Chantal ⁱ   Nobels, Frank ^j   Rottiers, Raoul ^a   Scheen, André ^a   Van Gaal, Luc ^b   Schuit, Frans C ^d   Van Der Auwera, Bart ^c   Rui, Mao ^e   De Pauw, Pieter ^f   Kaufman, Leonard ^g   Gorus, Frans K ^a  

^a DIABETES RESEARCH CENTER   (Belgium)

^b ERASME HOSPITAL   (Belgium)

^c Centre Hospitalier Universitaire de Charleroi   (Belgium)

^d UNIVERSITY OF LIÈGE   (Belgium)

^e ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^f UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^g GHENT UNIVERSITY HOSPITAL   (Belgium)

^h OLV HOSPITAL   (Belgium)

ⁱ VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^j Belgian Diabetes Registry   (Belgium)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; C PEPTIDE; HLA DQ ANTIGEN; INSULIN;

ADOLESCENT; ADULT; ARTICLE; BELGIUM; BLOOD SAMPLING; BODY MASS; CAUCASIAN; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; GENETIC SUSCEPTIBILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; HLA SYSTEM; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; KETONURIA; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SERODIAGNOSIS; SYMPTOMATOLOGY;

EID: 18444376462     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.87.6.8613     Document Type: Article

References (50)

1. Epidemiologic approach to the etiology of type 1 diabetes mellitus and impaired glucose tolerance in adults
2. Early environmental events as a cause of IDDM. Evidence and implications
3. Diabetes registries and early biological markers of insulin-dependent diabetes mellitus
4. Autoimmune (type 1) diabetes in young adults in Sweden
5. Incidence of insulin-dependent diabetes mellitus in age groups over 30 years in Denmark
6. The pathogenesis and prevention of diabetes in adults
7. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus
8. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1, Diagnosis and classification of diabetes mellitus: Provisional report of a WHO consultation
9. Diabetes and gender
10. A comparison of childhood and adult type 1 diabetes mellitus
11. Insulin autoantibodies and high titre islet cell antibodies are preferentially associated with the HLA DQA1*0301-DQB*0302 haplotype at clinical onset of type 1 (insulin-dependent) diabetes mellitus before age 10 years, but not at onset between age 10 and 40 years
12. Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus
13. Pancreatic β-cells in insulin-dependent diabetes
14. Male-to-female excess in diabetes diagnosed in early adulthood is not specific for the immune-mediated form nor is it HLA-DQ restricted: Possible relation to increased body mass index
15. Metabolic and immune parameters at clinical onset of insulin-dependent diabetes: A population-based study
16. UKPDS 25: Autoantibodies to islet cytoplasm and glutamic acid decarboxylase for prediction of insulin requirements in type 2 diabetes
17. Islet cell antibodies identify latent type 1 diabetes in patients aged 35-75 years at diagnosis
18. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies
19. Can all newly diagnosed subjects without type 1 diabetes-associated autoimmune markers be classified as type 1b diabetic patients?
20. Autoantibody negative new onset type 1 diabetic patients lacking high risk HLA genes in a Caucasian population: Are these type 1b diabetes cases?
21. Appearance of islet cell autoantibodies after clinical diagnosis of diabetes mellitus
22. High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of insulin-requiring type 1 diabetes presenting before 40 years of age
23. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance
24. Epidemiology, clinical aspects, and biology of IDDM patients under age 40 years
25. High diagnostic sensitivity of glutamate decarboxylase autoantibodies in insulin-dependent diabetes mellitus with clinical onset between age 20 and 40 years
26. Associations of GAD65- and IA-2-autoantibodies with genetic risk markers in new-onset IDDM patients and their siblings
27. Combined use of autoantibodies (IA2ab, GADab, IAA, ICA): Combinatorial islet autoantibody workshop
28. Complementation of HLA-DQA and -DQB genes confers susceptibility and protection to insulin-dependent diabetes mellitus
29. Genetic susceptibility for insulin-dependent diabetes mellitus in Caucasians revisited: The importance of diabetes registries in disclosing interactions between HLA-DQ- and insulin gene-linked risk
30. Relative and absolute HLA-DQA1-DQB1-linked risk for developing type 1 diabetes before age 40 years in the Belgian population: Implication for future prevention studies
31. Towards fully automated genome-wide polymorphism screening
32. Implantation of standardized β-cell grafts in a liver segment of IDDM patients: Graft and recipient characteristics in two cases of insulin-independence under maintenance immunosuppression for prior kidney graft
33. Abnormal circulating pancreatic enzyme activities in more than twenty-five percent of recent-onset insulin-dependent diabetic patients: Association of hyperlipasemia with high-titer islet cell antibodies
34. Multiple significance tests: The Bonferroni method
35. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease
36. Difficulties in classifying diabetes at presentation in the young adult
37. Clinical, immunological, and genetic heterogeneity of diabetes in an Italian population-based cohort of lean newly diagnosed patients aged 30-54 years
38. Genetic heterogeneity of autoimmune diabetes: Age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43)
39. Genetic, autoimmune, and clinical characteristics of childhood and adult-onset type 1 diabetes
40. HLA-DR3 is associated with a more slowly progressive form of type 1 (insulin-dependent) diabetes
41. Effect of genetic risk load defined by HLA DQB1 polymorphism on clinical characteristics of IDDM in children
42. Autoantibodies to a 38 kDa glycosylated islet cell membrane antigen are specific markers of (pre)type 1 diabetes: Association with autoantibodies against IA-2 and islet cell antigens
43. Rapid-onset type 1 diabetes with pancreatic endocrine dysfunction
44. Progression to insulin-requiring diabetes inseronegative prediabetic subjects: The role of two distinct HLA-DQ high-risk haplotypes
45. Idiopathic type 1 diabetes in Dallas, Texas. A 5-year experience
46. High frequency of mutation in MODY and mitochondrial genes in Scandinavian patients with familial early-onset diabetes
47. Diagnostic heterogeneity of diabetes in lean young adults. Classification based on immunologic and genetic parameters
48. Irs-2 coordinates Igf-1 receptor-mediated β-cell development and peripheral insulin signaling
49. The insulin gene VNTR is associated with fasting insulin levels and development of juvenile obesity